brand logo

Am Fam Physician. 2022;106(4):459-460

Author disclosure: No relevant financial relationships.

The Galleri test is a multicancer early detection blood test used to identify more than 50 cancer types in asymptomatic adults 50 years or older.1,2 It uses artificial intelligence analysis of cell-free DNA to recognize patterns associated with cancer and identify the likely tissue of origin. The Galleri test is not meant to replace current population-based cancer screening recommendations and is not approved by the U.S. Food and Drug Administration.3

TestIndicationPopulation, frequencyCost*
Galleri multi-cancer early detection testDetection of more than 50 cancer typesAsymptomatic adults with an elevated risk for cancer (such as those 50 years or older); performed annually$949
Already a member/subscriber?  Log In


From $165
  • Immediate, unlimited access to all AFP content
  • More than 130 CME credits/year
  • AAFP app access
  • Print delivery available

Issue Access

  • Immediate, unlimited access to this issue's content
  • CME credits
  • AAFP app access
  • Print delivery available
Purchase Access:  Learn More

This series is coordinated by Natasha Pyzocha, DO, contributing editor.

A collection of Diagnostic Tests published in AFP is available at

Continue Reading

More in AFP

More in PubMed

Copyright © 2022 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See permissions for copyright questions and/or permission requests.